{"url_path":"/fda/drug/recalls/D-0786-2026","section_key":"summary","section_title":"DRUG Recall: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-08-06","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0786-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"ACCORD HEALTHCARE, INC."},"word_count":79,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0786-2026\n\n**Recalling firm:** ACCORD HEALTHCARE, INC.\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-08-06\n**Report date:** 2026-09-02\n\n## Product\nLevothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15.\n\n## Reason\nSubpotent Drug\n\n## Affected lots\nLot #: D2402337, Exp. Date 10/31/2026.\n\n## Distribution\nNationwide within the United States"}